Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy.
Vitale MG, Crispo A, Arundine D, Ronga R, Barbato C, Luongo A, Habetswallner F, De Martino BM, Maione A, Eisenwagen S, Vitale G, Riccardi F. Vitale MG, et al. Among authors: barbato c. Front Pharmacol. 2022 Nov 8;13:874028. doi: 10.3389/fphar.2022.874028. eCollection 2022. Front Pharmacol. 2022. PMID: 36425572 Free PMC article.
ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-zeolite to prevent Chemotherapy-Induced Side Effects, in particular, Peripheral Neuropathy.
Vitale MG, Barbato C, Crispo A, Habetswallner F, Martino BM, Riccardi F, Maione A, Eisenwagen S, Vitale G, Cartenì G. Vitale MG, et al. Among authors: barbato c. Molecules. 2020 May 13;25(10):2297. doi: 10.3390/molecules25102297. Molecules. 2020. PMID: 32414185 Free PMC article. Clinical Trial.
First-line chemotherapy with liposomal doxorubicin plus cyclofosfamide in metastatic breast cancer: a case report of early and prolonged response.
Riccardi F, Mocerino C, Barbato C, Ambrosio F, Festino L, Vitale MG, Carrillo G, Trunfio M, Minelli S, Carteni G. Riccardi F, et al. Among authors: barbato c. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):773-8. doi: 10.1177/039463201302600323. Int J Immunopathol Pharmacol. 2013. PMID: 24067476 Free article.
Horner's syndrome: An unusual presentation of metastatic disease in breast cancer.
Vitale MG, Riccardi F, Carrillo G, Trunfio M, Mocerino C, Minelli S, Barbato C, Ambrosio F, Cartenì G. Vitale MG, et al. Among authors: barbato c. Int J Immunopathol Pharmacol. 2015 Dec;28(4):557-61. doi: 10.1177/0394632015602411. Epub 2015 Sep 24. Int J Immunopathol Pharmacol. 2015. PMID: 26405267 Free article.
Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study.
Romano FJ, Barbato C, Biglietto M, Di Lauro V, Arundine D, Fiorentino R, Ambrosio F, Cammarota M, Chiurazzi B, Puglia L, Scagliarini S, Ruocco R, Mocerino C, Cerillo I, Brangi MF, Riccardi F. Romano FJ, et al. Among authors: barbato c. Oncotarget. 2021 Feb 2;12(3):221-229. doi: 10.18632/oncotarget.27872. eCollection 2021 Feb 2. Oncotarget. 2021. PMID: 33613849 Free PMC article.
Neuroendocrine tumors diagnosed at the Antonio Cardarelli hospital (Naples, Italy) between 2006-2009: a single-institution analysis.
Riccardi F, Nappi O, Balzano A, De Palma M, Buonerba C, Rizzo M, Barbato C, De Dominicis G, Buonocore U, De Sena G, Lastoria S, Molino C, Monaco G, Rabitti PG, Romano L, Scavuzzo F, Suozzo R, Uomo G, Volpe R, Di Lorenzo G, Carteni G. Riccardi F, et al. Among authors: barbato c. Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):251-6. doi: 10.1177/039463201102400132. Int J Immunopathol Pharmacol. 2011. PMID: 21496411 Free article.
Smelling TNT: Trends of the Terminal Nerve.
Ruqa WA, Pennacchia F, Rusi E, Zoccali F, Bruno G, Talarico G, Barbato C, Minni A. Ruqa WA, et al. Among authors: barbato c. Int J Mol Sci. 2024 Mar 31;25(7):3920. doi: 10.3390/ijms25073920. Int J Mol Sci. 2024. PMID: 38612730 Free PMC article. Review.
116 results